تقرير
Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report
العنوان: | Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report |
---|---|
المؤلفون: | Chan, Steven M, George, Tracy, Cherry, Athena M, Medeiros, Bruno C |
بيانات النشر: | BioMed Central Ltd. |
سنة النشر: | 2009 |
المجموعة: | BioMed Central |
الوصف: | Background Plasma cell leukemia (PCL) is a rare lymphoproliferative disorder considered to be a variant of multiple myeloma. It is an aggressive disease with a poor clinical response to standard chemotherapeutic agents. Case presentation A novel regimen consisting of bortezomib, doxorubicin, and dexamethasone is currently under active evaluation for the treatment of multiple myeloma. We employed this combination as front-line chemoinduction therapy for a case of primary PCL. Conclusion Complete remission was achieved with rapid normalization of hematologic parameters. The combination of bortezomib, doxorubicin and dexamethasone demonstrates promise in the treatment of PCL. |
نوع الوثيقة: | report |
اللغة: | English |
العلاقة: | http://www.casesjournal.com/content/2/1/121Test |
الإتاحة: | http://www.casesjournal.com/content/2/1/121Test |
حقوق: | Copyright 2009 Chan et al; licensee BioMed Central Ltd. |
رقم الانضمام: | edsbas.83FC6E14 |
قاعدة البيانات: | BASE |
كن أول من يترك تعليقا!